Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by alleyesonmeon Oct 04, 2023 12:35pm
47 Views
Post# 35669289

RE:RE:RE:RE:RE:who

RE:RE:RE:RE:RE:whoNot stupid questions, very GOOD questions!, and an important discussion. MPL does have final acceptance from the FDA on the facility in Barrie and acceptance for the cannabinol drug masterfile....as does JAZZ...if your a pharmaceutical Corp developing a new cannabiniod drug you will not contact the leading pharmaceutical company in this field JAZZ to formulate your API, JAZZ is in the business of development where as MPL is in the business of cannabinoid API supply..The pharmaceutical Corp would have to tell JAZZ indication, dosage, formulation and trial details for  JAZZ to be able to apply for export into the U.S..this information is to secretive to share with the largest cannabinoid drug manufacturer/pipeline on the planet...it will never happen..
<< Previous
Bullboard Posts
Next >>